CorVel Corp (CRVL) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of CorVel Corp stock $39.94, price $83.16, that is 52.0% below the price, quality 68 out of 100. Rating: strongly overvalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range $43.99 – $128.46 · fair‑value band $29.95 – $49.92 · the $83.16 price screens above the $39.94 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow CorVel in your weekly email
Every Wednesday you see whether CorVel is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.
Show moreShow less
It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance.
The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.
CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
Stock analysis
CorVel Corp (CRVL) currently trades at $83.16, while our model-based Fair Value estimate is $39.94, 52% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $39.94 per share, and 0 of the 4 models we run sit above the $83.16 price.
Bear case: the Asset-Based group reads lowest at $4.23, and 4 of the 4 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $29.95 (bear) to $49.92 (bull), the price of $83.16 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CorVel Corp reported revenue of $959M in FY2026 versus $646M in FY2022, a compound +10.4%/yr. Reported net income was $110M in FY2026, compounding +13.5%/yr from FY2022.
Key figures
Market cap $4.3B Mid · P/E ratio 34.9 · P/S ratio 4.36 · EPS (TTM) $2.38 · Net margin 11.7% · Return on equity 30.7% · Return on assets (EBIT) 21.4% (5-year average) · Operating margin 16.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 75 out of 100 (low confidence).
What moves the price
The share trades about 5% below its 52-week high and 81% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −61% fair-value upside, at −52%, CRVL screens cheaper than that median.
Fair Value models
Bear$29.95Fair Value $39.94Bull$49.92
Price $83.16 · Downside -52.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then ($1.45 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 5 officers or directors sold shares worth $3.2M and none bought.
SaleCORSTAR HOLDINGS INC10% owner2× since Sep 3, 2026: 225,000 shares, avg. $69.63$15.7MSep 14, 202610b5-1 plan
SaleR Judd JessupDirector3× since Nov 10, 2025: 14,133 shares, avg. $73.72$1.0MSep 1, 2026
SaleJennifer YossVice President of Accounting2× since May 26, 2026: 4,099 shares, avg. $66.09$270,911Aug 20, 2026
SaleMichael G CombsCEO & President4× since Mar 9, 2026: 36,513 shares, avg. $59.28$2.2MJun 12, 2026
SaleMaxim ShishinChief Information Officer2× since Mar 16, 2026: 4,650 shares, avg. $57.19$265,928Jun 12, 2026
SaleJeffrey J MichaelDirector, 10% owner9,000 shares at $60.98$548,820Jun 9, 2026
SaleSteven J HamerslagDirector20,000 shares at $47.79$955,800Feb 13, 2026
SaleMark E. BertelsEVP - Risk Management Services1,200 shares at $72.35$86,820Nov 19, 2025
Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.6%
Start year 2021 (pandemic). Over 10 years: +6.6% a year
Revenue growth 35 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.1%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−3.1% vs 4.1%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 15%
Pace: the 5-year rate starts in 2021 (pandemic)
⚠ Revenue per share shrinking 3.1%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+21.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +18.8% a year for the price.
News mood ⓘNews mood, the average tone of recent news (75 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Moderate profitability supports CorVel's managed care brokerage, yet thin public signals limit any firm conclusions on durable competitive advantages.
Main risk: Slow carrier adoption of the CareMC Accelerator would constrain growth in claims management workflows and data integration services.
CorVel recently launched its CareMC Accelerator to let insurers launch and track managed care services straight inside Guidewire ClaimCenter. The integration promises smoother workflows and tighter data links, yet it is unclear whether enough carriers will adopt it fast enough to offset the premium valuation our models currently assign. Will deeper platform ties mainly reinforce the existing client base or unlock broader growth in claims management?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance Brokers · 31 stocks
Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score68 · Above median
Fair Value upside−52.0% · Below median
Profitability
Return on equity (12 months)30.7% · Top 25%
Return on assets17.2% · Top 25%
Net margin (12 months)11.7% · Below median
Operating margin (12 months)16.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)10.7% · Above median
Valuation Multiplesvs Insurance Brokers median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CorVel Corp Fair Value". https://www.fairvalue-calculator.com/stock/CRVL
Frequently asked questions
Is CorVel Corp (CRVL) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $39.94 versus a price of $83.16, about 52% lower (overvalued).
What is the fair value of CRVL?
Our model-based fair value for CorVel Corp is $39.94 (as of Nov 5, 2026), built from audited fundamentals. The current price: $83.16.
What is the quality score of CRVL?
CorVel Corp has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CorVel Corp (CRVL)?
Our model-based price target is the fair value of $39.94 (as of Nov 5, 2026) from 4 valuation models. Cautious scenario $29.95, optimistic scenario $49.92. It is a calculation from audited fundamentals, not an analyst target.
What is the CorVel Corp stock forecast for 2026?
Our models put fair value at $39.94, about 52% lower versus a price of $83.16 (overvalued). Cautious scenario $29.95, optimistic scenario $49.92. The calculation is refreshed regularly with new filings.
What is the revenue of CorVel Corp (CRVL)?
CorVel Corp reported trailing-twelve-month revenue of about $984M (latest available figure, as of Nov 5, 2026).
What growth is priced into CorVel Corp (CRVL)?
For today's price to be fair in a discounted-cash-flow model, CorVel Corp would have to grow free cash flow by +21.6 % per year for five years (discount rate 9.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.6 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of CRVL use?
Our models discount CorVel Corp at 9.9 %: a base by market capitalisation (mid), damped by beta 1.08, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CorVel Corp that is +21.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.9 %) and the same formula as our fair value.
How much growth has CorVel Corp (CRVL) delivered so far?
Over the past 5 years revenue at CorVel Corp grew +11.6 % a year. The price currently implies free-cash-flow growth of +21.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CorVel Corp (CRVL) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into CorVel Corp (+21.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CorVel Corp (CRVL)?
The free-cash-flow yield on the price is 2.57 %: that much free cash flow CorVel Corp produces per unit of market value. When it exceeds the discount rate of our models (9.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CorVel Corp (CRVL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CorVel Corp it is $39.94 per share (as of Nov 5, 2026), against a price of $83.16. It is the blended result of 4 valuation models in 3 families (Multiples, Asset-Based, Economic Profit).
Is CorVel Corp stock overvalued or undervalued in 2026?
As of Nov 5, 2026, CRVL trades above its calculated fair value: price $83.16, fair value $39.94, a gap of about −52% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRVL?
No. The price is what the market pays today ($83.16); the fair value is what the company's own numbers justify ($39.94). For CorVel Corp the two are $43.22 per share apart. That gap is exactly why we show both numbers side by side.
How much is CorVel Corp worth?
The market values CorVel Corp at about $4.3B (market capitalisation, as of Nov 5, 2026). Per share that is $83.16; our models calculate a fair value of $39.94 per share.
What do the bullish and bearish scenarios say about CRVL?
Our models span a range for CorVel Corp: cautious scenario $29.95, base $39.94, optimistic $49.92 per share (as of Nov 5, 2026, price $83.16). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CRVL?
CorVel Corp trades at a price-to-earnings ratio of 34.9 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $39.94 is built from several models across several years. Other multiples: P/B 10.9, P/S 4.4, EV/EBITDA 22.1.
How solid is the balance sheet of CorVel Corp (CRVL)?
Balance-sheet figures for CorVel Corp (as of Nov 5, 2026): return on equity 30.7%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is CRVL from its 52-week high?
CorVel Corp trades at $83.16, about 5% below its 52-week high of $87.38 and 81% above the low of $46.00 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $39.94 is for.
Which stocks are comparable to CorVel Corp?
From the same area (Financial Services) we also value Marsh & McLennan Companies, Inc, Arthur J. Gallagher & Co, Aon plc, Willis Towers Watson Public Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CorVel Corp stock attractive at the current price?
The data as of Nov 5, 2026: price $83.16, calculated fair value $39.94 (−52%), Quality Score 68/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRVL calculated?
We run CorVel Corp through 4 models from 3 families: Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of $39.94 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. CorVel Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CorVel Corp (CRVL)?
The closing price on Nov 6, 2026 was $83.16. Our model-based fair value is $39.94, about 52% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CorVel Corp right now?
The price sits above even our optimistic bull case ($49.92). The favourable scenario is already priced in. Solid but not exceptional quality (68/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of CorVel Corp (CRVL) come from?
Earnings per share at CorVel Corp grew +2.6 % a year from 2015 to 2026. Broken into its drivers: revenue per share −4.2 %, EBIT margin +4.4 %, tax rate +2.6 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of CorVel Corp
How large is the market capitalisation of CorVel Corp (CRVL)?
The market capitalisation of CorVel Corp is $4.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CorVel Corp (CRVL)?
The price-to-sales ratio of CorVel Corp is 4.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CorVel Corp (CRVL)?
Earnings per share at CorVel Corp are $2.38 (price ÷ EPS = P/E 34.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of CorVel Corp (CRVL)?
The net margin of CorVel Corp is 11.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CorVel Corp (CRVL)?
The return on equity (ROE) of CorVel Corp is 30.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CorVel Corp (CRVL)?
On an EBIT basis the return on assets of CorVel Corp is 21.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CorVel Corp (CRVL)?
The operating margin of CorVel Corp is 16.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CorVel Corp (CRVL)?
Revenue at CorVel Corp is growing +10.7% versus a year earlier (3y avg +10.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CorVel Corp (CRVL)?
Earnings per share at CorVel Corp are growing +21.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does CorVel Corp (CRVL) hold?
CorVel Corp holds more cash than debt, $212M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch CorVel Corp in the live analysis
One click puts CorVel Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026